322 TET2 mutations, methylation profile and prognosis in higher risk myelodysplastic syndromes (MDS) treated with 5-azacytidine and valproic acid
Titel:
322 TET2 mutations, methylation profile and prognosis in higher risk myelodysplastic syndromes (MDS) treated with 5-azacytidine and valproic acid
Auteur:
Voso, M.T. Fabiani, E. Piciocchi, A. Matteucci, C. Brandimarte, L. Finelli, C. Pogliani, E. Angelucci, E. Maurillo, L. Musto, P. Buccisano, F. Hohaus, S. Vignetti, M. Santini, V. Leone, G. Mecucci, C.